Skip to main content
. Author manuscript; available in PMC: 2020 May 1.
Published in final edited form as: Alzheimers Dement. 2019 Feb 10;15(5):709–719. doi: 10.1016/j.jalz.2018.12.010

Table 1: CLINICAL CHARACTERISTICS OF ILE416THR CARRIERS AND NON-CARRIERS.

Age at evaluation and age at onset are given as Mean and Standard Deviation. NPI-Q: Cummings Neuropsychiatric Inventory-Questionnaire IR: interquartile range CDR: clinical dementia rating. MCI mild cognitive impairment

Non-carriers Ile416Thr carriers
Total n= 67 Total n= 26 Asymptomatic n=14 MCI n=4 Dementia n=8
Age at onset NA NA NA 47.6 (5.8) 51.6 (5.0)
Age at evaluation 36.5 (14.3) 46.0 (14.4) 36.5 (12.0) 50.8 (3.8) 59.1 (8.7)
CDR
0 (None) 63 (94%) 14 (53,9%) 14 (100%) 0 0
0.5 (Questionable) 4 (6%) 4 (15.4%) 0 4 (100%) 0
1 (Mild) 0 3 (11.5%) 0 0 3 (37.5%)
2 (Moderate) 0 2 (7.7%) 0 0 2 (25%)
3 (Severe) 0 3 (11.5%) 0 0 3 (37.5%)
Depression symptoms 7 (10.4%) 8 (30,8%) 1 (7.1%) 1 (25%) 6 (75%)
Anxiety symptoms 0 6 (23,1%) 1 (7.1%) 1 (25%) 4 (50%)
Delusions 0 3 (11.5%) 0 1 (25%) 2 (25%)
Hallucinations 0 3 (11.5%) 0 1 (25%) 2 (25%)
Insomnia 0 4 (15.4%) 0 1 (25%) 3 (37.5%)
NPI-Q median (IR) 0 (4) 2,00 (10,50) 0,00 (6,25) 9,5 (21,00) 41(NA)
Myoclonus 0 5 (19.2%) 0 0 5 (62.5%)
Seizures 0 4 (15.4%) 0 0 4 (50%)
Traumatic Brain Injury 9 (13,4%) 2 (7.7%) 1 (7.1%) 1 (25%) 0
Headache 0 4 (15.4%) 1 (7.1%) 2 (50%) 1 (12.5%)
Alcoholism 2 (3%) 4 (15.4%) 1 (7.1%) 0 3 (37.5%)
Tobacco use 14 (20,9%) 11 (42.3%) 5 (35.7%) 2 (50%) 4 (50%)
Drug abuse 6 (9%) 2 (7.7%) 2 (14.3%) 0 0
Learning difficulties 11 (16.4%) 4 (15.4%) 3 1 0